Logo image of PHVS

PHARVARIS NV (PHVS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PHVS - NL00150005Y4 - Common Stock

27.72 USD
+2.27 (+8.92%)
Last: 11/26/2025, 8:00:00 PM
27.6 USD
-0.12 (-0.43%)
After Hours: 11/26/2025, 8:00:00 PM
Fundamental Rating

2

PHVS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. PHVS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHVS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PHVS had negative earnings in the past year.
In the past year PHVS has reported a negative cash flow from operations.
PHVS had negative earnings in each of the past 5 years.
PHVS had a negative operating cash flow in each of the past 5 years.
PHVS Yearly Net Income VS EBIT VS OCF VS FCFPHVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -80.21%, PHVS is doing worse than 71.88% of the companies in the same industry.
PHVS has a Return On Equity of -91.30%. This is comparable to the rest of the industry: PHVS outperforms 42.19% of its industry peers.
Industry RankSector Rank
ROA -80.21%
ROE -91.3%
ROIC N/A
ROA(3y)-38.96%
ROA(5y)-32.55%
ROE(3y)-42.51%
ROE(5y)-35.1%
ROIC(3y)N/A
ROIC(5y)N/A
PHVS Yearly ROA, ROE, ROICPHVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

PHVS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHVS Yearly Profit, Operating, Gross MarginsPHVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

PHVS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PHVS has been increased compared to 5 years ago.
The debt/assets ratio for PHVS is higher compared to a year ago.
PHVS Yearly Shares OutstandingPHVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PHVS Yearly Total Debt VS Total AssetsPHVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 31.56 indicates that PHVS is not in any danger for bankruptcy at the moment.
PHVS's Altman-Z score of 31.56 is amongst the best of the industry. PHVS outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PHVS is not too dependend on debt financing.
PHVS's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. PHVS outperforms 61.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.56
ROIC/WACCN/A
WACCN/A
PHVS Yearly LT Debt VS Equity VS FCFPHVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

PHVS has a Current Ratio of 8.33. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 8.33, PHVS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
PHVS has a Quick Ratio of 8.33. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 8.33, PHVS is doing good in the industry, outperforming 75.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.33
Quick Ratio 8.33
PHVS Yearly Current Assets VS Current LiabilitesPHVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.06% over the past year.
EPS 1Y (TTM)6.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 21.05% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-15.82%
EPS Next 2Y-6.14%
EPS Next 3Y5.61%
EPS Next 5Y21.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHVS Yearly Revenue VS EstimatesPHVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
PHVS Yearly EPS VS EstimatesPHVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6 8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHVS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHVS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHVS Price Earnings VS Forward Price EarningsPHVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHVS Per share dataPHVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.14%
EPS Next 3Y5.61%

More info and screens

0

5. Dividend

5.1 Amount

PHVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PHARVARIS NV

NASDAQ:PHVS (11/26/2025, 8:00:00 PM)

After market: 27.6 -0.12 (-0.43%)

27.72

+2.27 (+8.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)04-06 2026-04-06/amc
Inst Owners50.36%
Inst Owner Change30.59%
Ins Owners5.32%
Ins Owner ChangeN/A
Market Cap1.78B
Revenue(TTM)N/A
Net Income(TTM)-168.29M
Analysts86.67
Price Target37.83 (36.47%)
Short Float %1.2%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.38%
Min EPS beat(2)-9.19%
Max EPS beat(2)-5.58%
EPS beat(4)1
Avg EPS beat(4)-6.35%
Min EPS beat(4)-23.64%
Max EPS beat(4)12.99%
EPS beat(8)4
Avg EPS beat(8)-5.98%
EPS beat(12)7
Avg EPS beat(12)-3.82%
EPS beat(16)11
Avg EPS beat(16)5.52%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.45%
PT rev (3m)11.45%
EPS NQ rev (1m)1.71%
EPS NQ rev (3m)12.72%
EPS NY rev (1m)0%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.32
P/tB 8.32
EV/EBITDA N/A
EPS(TTM)-2.87
EYN/A
EPS(NY)-3.23
Fwd EYN/A
FCF(TTM)-2.48
FCFYN/A
OCF(TTM)-2.47
OCFYN/A
SpS0
BVpS3.33
TBVpS3.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -80.21%
ROE -91.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.96%
ROA(5y)-32.55%
ROE(3y)-42.51%
ROE(5y)-35.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 178.39%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.33
Quick Ratio 8.33
Altman-Z 31.56
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)104.84%
Cap/Depr(5y)175.41%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-15.82%
EPS Next 2Y-6.14%
EPS Next 3Y5.61%
EPS Next 5Y21.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-22.2%
EBIT Next 3Y-4.38%
EBIT Next 5Y24.49%
FCF growth 1Y-68.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.14%
OCF growth 3YN/A
OCF growth 5YN/A

PHARVARIS NV / PHVS FAQ

Can you provide the ChartMill fundamental rating for PHARVARIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to PHVS.


Can you provide the valuation status for PHARVARIS NV?

ChartMill assigns a valuation rating of 0 / 10 to PHARVARIS NV (PHVS). This can be considered as Overvalued.


Can you provide the profitability details for PHARVARIS NV?

PHARVARIS NV (PHVS) has a profitability rating of 0 / 10.


How financially healthy is PHARVARIS NV?

The financial health rating of PHARVARIS NV (PHVS) is 5 / 10.